Physician profile

John Thompson

Pulmonary Disease · Lexington, KY

NPI 1760496301

$76,932.87

in general payments reported to CMS, 2019-2025

50 companies · $2,649 in 2025

The $2,649 reported for 2025 was more than what 81% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$17,700.00
Food and Beverage$6,252.76
Consulting Fee$3,200.00
Education$3,189.94
Travel and Lodging$1,628.59
Gift$390.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boehringer Ingelheim Pharmaceuticals, INC. $63,078.00 2019-2025 Ofev, Stiolto Respimat, Spiriva Respimat
Intuitive Surgical, INC. $3,431.36 2023-2025 Ion, Da Vinci Surgical System
Glaxosmithkline, LLC. $1,564.63 2019-2025 Nucala, Trelegy Ellipta, Arexvy
Astrazeneca Pharmaceuticals Lp $1,299.73 2019-2025 Fasenra, Airsupra, Breztri
Grifols USA, LLC $723.48 2019-2025 Prolastin-C Liquid
Mylan Specialty L.P. $701.40 2019-2024 Yupelri
Actelion Pharmaceuticals US, INC. $700.60 2019-2025 Uptravi, Opsumit
Regeneron Healthcare Solutions, INC. $600.61 2019-2025 Dupixent
Genzyme Corporation $553.88 2019-2025
United Therapeutics Corporation $327.49 2021-2024 Tyvaso
Pfizer INC. $309.08 2021-2025
Takeda Pharmaceuticals U.S.A., INC. $308.92 2020-2025 Aralast
Amgen INC. $298.41 2022-2025 Tezspire, Tavneos
Genentech USA, INC. $285.13 2019-2023 Xolair
Insmed, INC. $197.56 2019-2024 Arikayce
Show all 50 companies
CompanyGeneral paymentsYearsTop products
Merck Sharp & Dohme LLC $197.08 2019-2025 Zerbaxa
Viatris Specialty LLC $185.41 2025 Yupelri
Gilead Sciences, INC. $182.22 2019-2024 Veklury
Novartis Pharmaceuticals Corporation $166.28 2019-2020
Mallinckrodt Hospital Products INC. $162.28 2022-2024 Acthar
Janssen Pharmaceuticals, INC $130.60 2019-2022
Verona Pharma, INC. $113.38 2025 Ohtuvayre
Axsome Therapeutics, INC. $110.76 2023-2025 Sunosi
Mayne Pharma Commercial LLC $105.82 2019-2021
Teleflex LLC $105.20 2025 Arrow
Sanofi-Aventis U.S. LLC $99.95 2023
Paratek Pharmaceuticals, INC. $98.14 2021-2025 Nuzyra
Circassia INC. $86.87 2019
Tempus Ai, INC $86.86 2024 Xt Cdx
Pulmonx Corporation $70.40 2023-2024 Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve
Abbvie INC. $68.50 2021-2022
Portola Pharmaceuticals, LLC $60.03 2019-2020
Shire North American Group INC $58.39 2019
Sunovion Pharmaceuticals INC. $57.87 2019
Philips North America LLC $54.06 2025 Vest Therapy Und
Baxter Healthcare $46.65 2023-2024 Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care
Allergan, INC. $36.17 2019
Fisher & Paykel Healthcare INC $33.52 2019
Vifor Pharma, INC. $31.80 2025 Zemaira
Inogen, INC. $28.15 2023-2024 Inogen One G5 Oxygen Concentrator - Bluetooth
Teva Pharmaceuticals USA, INC. $25.76 2022
Electromed, INC. $24.21 2021
Tactile Systems Technology INC $20.43 2022
Siemens Medical Solutions USA, INC. $18.16 2024 Cios Spin
Resmed Corp $16.82 2023
Csl Behring $15.33 2025 Kcentra
Astellas Pharma US INC $14.95 2019
E.R. Squibb & Sons, L.L.C. $14.07 2023 Opdivo
Azurity Pharmaceuticals, INC. $13.61 2025 Alvesco
Medtronic, INC. $12.86 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

John Thompson

$76,932.87

in general payments reported 2019-2025

Years
2019-2025
Top company
Boehringer Ingelheim Pharmaceuticals, INC.
Context
The $2,649 reported for 2025 was more than what 81% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/307480/john-thompson

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.